Find similar content

Source channel @githubtrending · Post #14712 · May 16

#php#calendar#contacts#crm#crm_platform#crm_system#customer_portal#customer_support#customizable#documents#email_marketing#kanban#leads#open_source#php#platform#sales_automation#single_page_application#support EspoCRM is a free, open-source CRM tool that helps you manage customer relationships by organizing leads, contacts, sales, marketing, and support in one easy-to-use web app. It has a clean interface, customizable features, and a REST API for integration, making it flexible for startups, small businesses, and developers. It automates repetitive tasks, saving time and reducing errors, while providing detailed reports to improve decision-making. Being open-source, it’s cost-effective with no licensing fees, and supported by a helpful community. This means you get a powerful, adaptable CRM that boosts productivity and customer management without high costs[1][3][5]. https://github.com/espocrm/espocrm

Hashtags

#php #calendar #contacts #crm #crm_platform #crm_system #customer_portal #customer_support #customizable #documents #email_marketing #kanban #leads #open_source #platform #sales_automation #single_page_application #support

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment